BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 18094026)

  • 1. The chromatin-remodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development.
    Griffin CT; Brennan J; Magnuson T
    Development; 2008 Feb; 135(3):493-500. PubMed ID: 18094026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SWI/SNF chromatin-remodeling enzymes Brahma-related gene 1 (BRG1) and Brahma (BRM) are dispensable in multiple models of postnatal angiogenesis but are required for vascular integrity in infant mice.
    Wiley MM; Muthukumar V; Griffin TM; Griffin CT
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25904594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRG1 (Brahma-Related Gene 1) Promotes Endothelial
    Menendez MT; Ong EC; Shepherd BT; Muthukumar V; Silasi-Mansat R; Lupu F; Griffin CT
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1674-1682. PubMed ID: 28729363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Brg1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI/SNF-related complexes in beta-globin expression and erythroid development.
    Bultman SJ; Gebuhr TC; Magnuson T
    Genes Dev; 2005 Dec; 19(23):2849-61. PubMed ID: 16287714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chromatin-remodeling enzymes BRG1 and CHD4 antagonistically regulate vascular Wnt signaling.
    Curtis CD; Griffin CT
    Mol Cell Biol; 2012 Apr; 32(7):1312-20. PubMed ID: 22290435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional redundancy of SWI/SNF catalytic subunits in maintaining vascular endothelial cells in the adult heart.
    Willis MS; Homeister JW; Rosson GB; Annayev Y; Holley D; Holly SP; Madden VJ; Godfrey V; Parise LV; Bultman SJ
    Circ Res; 2012 Aug; 111(5):e111-22. PubMed ID: 22740088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SWI/SNF complexes containing Brahma or Brahma-related gene 1 play distinct roles in smooth muscle development.
    Zhang M; Chen M; Kim JR; Zhou J; Jones RE; Tune JD; Kassab GS; Metzger D; Ahlfeld S; Conway SJ; Herring BP
    Mol Cell Biol; 2011 Jul; 31(13):2618-31. PubMed ID: 21518954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers.
    Papillon JPN; Nakajima K; Adair CD; Hempel J; Jouk AO; Karki RG; Mathieu S; Möbitz H; Ntaganda R; Smith T; Visser M; Hill SE; Hurtado FK; Chenail G; Bhang HC; Bric A; Xiang K; Bushold G; Gilbert T; Vattay A; Dooley J; Costa EA; Park I; Li A; Farley D; Lounkine E; Yue QK; Xie X; Zhu X; Kulathila R; King D; Hu T; Vulic K; Cantwell J; Luu C; Jagani Z
    J Med Chem; 2018 Nov; 61(22):10155-10172. PubMed ID: 30339381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development.
    Smith-Roe SL; Bultman SJ
    Mamm Genome; 2013 Feb; 24(1-2):21-9. PubMed ID: 23076393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels.
    Griffin CT; Curtis CD; Davis RB; Muthukumar V; Magnuson T
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2282-7. PubMed ID: 21262838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brg1 Enables Rapid Growth of the Early Embryo by Suppressing Genes That Regulate Apoptosis and Cell Growth Arrest.
    Singh AP; Foley JF; Rubino M; Boyle MC; Tandon A; Shah R; Archer TK
    Mol Cell Biol; 2016 Aug; 36(15):1990-2010. PubMed ID: 27185875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes.
    Sena JA; Wang L; Hu CJ
    Mol Cell Biol; 2013 Oct; 33(19):3849-63. PubMed ID: 23897427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.
    Wilson BG; Helming KC; Wang X; Kim Y; Vazquez F; Jagani Z; Hahn WC; Roberts CW
    Mol Cell Biol; 2014 Mar; 34(6):1136-44. PubMed ID: 24421395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SWI/SNF chromatin remodeling subunit Smarca4/BRG1 is essential for female fertility†.
    Abedini A; Landry DA; Macaulay AD; Vaishnav H; Parbhakar A; Ibrahim D; Salehi R; Maranda V; Macdonald E; Vanderhyden BC
    Biol Reprod; 2023 Feb; 108(2):279-291. PubMed ID: 36440965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Casein kinase 2-mediated phosphorylation of Brahma-related gene 1 controls myoblast proliferation and contributes to SWI/SNF complex composition.
    Padilla-Benavides T; Nasipak BT; Paskavitz AL; Haokip DT; Schnabl JM; Nickerson JA; Imbalzano AN
    J Biol Chem; 2017 Nov; 292(45):18592-18607. PubMed ID: 28939766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SRG3, a core component of mouse SWI/SNF complex, is essential for extra-embryonic vascular development.
    Han D; Jeon S; Sohn DH; Lee C; Ahn S; Kim WK; Chung H; Seong RH
    Dev Biol; 2008 Mar; 315(1):136-46. PubMed ID: 18206867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin remodeling complexes interact dynamically with a glucocorticoid receptor-regulated promoter.
    Johnson TA; Elbi C; Parekh BS; Hager GL; John S
    Mol Biol Cell; 2008 Aug; 19(8):3308-22. PubMed ID: 18508913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
    Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
    Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
    Medina PP; Sanchez-Cespedes M
    Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.